MedTrace Logo

Clinical Trial of Clinical Efficiency and Safety of Ergoferon in Treatment of Influenza

NCT01804946 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2015-06-23

Study results available
· View outcomes & findings →

Summary

The purpose of this study is:

* to assess clinical efficiency of Ergoferon for treatment of influenza
* to assess safety of Ergoferon for treatment of influenza
* to compare efficiency of Ergoferon and Tamiflu for treatment of influenza

Conditions

Interventions

DRUG

Ergoferon

Safety and Efficiency of Ergoferon in treatment of Influenza

DRUG

Oseltamivir

Safety and Efficiency in treatment of Influenza

Sponsors & Collaborators

  • Materia Medica Holding

    lead INDUSTRY

Principal Investigators

  • Mikhail Putilovskiy, MD, PhD · Materia Medica Holding

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-04-30
Completion
2014-10-31

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01804946 on ClinicalTrials.gov